53
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28

Pages 282-287 | Published online: 12 Jul 2009

Reference

  • van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975;293:517–20.
  • Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613–23.
  • 011ier W, Venables PJ, Mumford PA, et al. HLA antigen associations with extra-articular rheumatoid arthritis. Tissue Antigens 1984;24: 279–91.
  • Kitas GD, Salmon M, Farr M, Gaston JSH, Bacon PA. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Clin Exp Immunol 1988;73: 242–9.
  • Seitz M, Deiman W, Gram N, Hunstein W, Gemsa G. Characterisation of blood mononuclear cells of rheumatoid arthritis patients. I. depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol 1982;25:405–16.
  • Lotz M, Tsoukas CD, Robinson CA, Dinarello CA, Carson DA, Vaughan JH. Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) anti-bodies. J Clin Invest 1986;78:713–21.
  • Noun i AM, Panayi GS. Cytokines and the chronic inflamma-tion of rheumatic disease. III. Deficient interleukin-2 produc-tion in rheumatoid arthritis is not due to suppressor mechanisms. J Rheumatol 1987;14:902–6.
  • Howell WM, Warren CJ, Cook NJ, Cawley MI, Smith JL. Detection of IL-2 at mRNA and protein levels in synovial infiltrates from inflammatory arthropathies using biotinylated oligonucleotide probes in situ. Clin Exp Immunol 1991; 86:393–8.
  • Wong WM, Howell WM, Coy SD, Cawley MI, Smith JL. Interleukin-2 is found in the synovium of psoriatic arthritis and spondyloarthritis, not in rheumatoid arthritis. Scand J Rheumatol 1996;25: 239–45.
  • Zvaifler NJ, Firestein GS. Pannus and pannocytes: alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 1994;37:783–9.
  • Glennie MJ, Tutt AL, Greenman J. Preparation of multi-specific F(ab)2 and F(ab)3 antibody derivatives. In: Gallagher G, Rees RC, Reynolds CW. eds. Tumour immunobiology, a practical approach. Oxford: Oxford University Press, 1993:225–44.
  • Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197–207.
  • Smith MD, Roberts-Thomson PJ. Interleukin 2 and inter-leukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and inter-leukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis, and Reiter's syndrome. J Rheumatol 1989;16: 897–903.
  • Hovdenes J, Gaudemack G, Kvien TK, Hovdenes AB, Egeland T. Mitogen-induced interleukin 2 and gamma interferon production by CD4+ and CD8+ cells of patients with inflammatory arthritides. A comparison between cells from synovial fluid and peripheral blood. Scand J Immunol 1989;30: 597–603.
  • Rivas D, Mozo L, Zamorano J, Gayo A, Torre-Alonso JC, Rodriguez A, et al. Upregulated expression of IL-4 receptors and increased levels of IL-4 in rheumatoid arthritis patients. J Autoimmun 1995;8: 587–600.
  • Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from rheumatoid synovial membrane functionally represent the Thl subset. Scand J Immunol 1992;35:603–10.
  • Miossec P, Naviliat M, Dupuy D'Angeac A, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum 1990;33: 1180–7.
  • Zenmyo M, Hiraoka K, Sasaguri T, Komiya S, Inoue A, Morimatsu M, et al. Interleukin-4 stimulates rheumatoid synovial fibroblasts to express matrix metalloproteinase-1 (tissue collagenase) and histamine Hi receptor mRNA. Biochem Mol Biol Int 1996;40:1253–60.
  • van Roon JA, van Roy JL, Duits A, Lafeber FP, Bijlsma JW. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995;54:836–40.
  • Fong KY, Boey ML, Koh WH, Feng PH. Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions. Clin Exp Rheumatol 1994;12:55–8.
  • Tebib JG, Boughaba H, Letroublon MC, et al. Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression. Eur Cytokine Netw 1991;2:239–43.
  • Lavelle-Jones M, al-Hadrani A, Spiers EM, Campbell FC, Cuschieri A. Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease. BMJ 1990;301: 97.
  • Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Form O, Natvig JB. Rheumatoid inflammatory T-cell clones express mostly Thl but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993;38: 75–82.
  • Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1961–9.
  • Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562–6.
  • Kusuba M, Honda J, Fukuda T, Oizumi K. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol 1998; 25:1466–71.
  • van der Graaf WL, Prins AP, Niers TM, Dijkmans BA, van Lier RA. Quantitation of interferon-gamma- and interleukin-4-producing T cells in peripheral blood and synovial fluid of rheumatoid arthritis patients. Rheumatology (Oxford) 1999; 38:214–20.
  • Morita Y, Yamamura M, Kawashima M, Harada S, Tsuji K, Shibuya K, et al. Flow cytometric single cell analysis of cytokine production by CD4 + T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1669–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.